Finance Tutor

🚀 Anthem Biosciences: The Next Multibagger? Mutual Funds are Betting BIG! 🔥



Big names like Quant, Axis, HDFC Mutual Funds have loaded up on Anthem Biosciences – but is this India’s next pharma superstar?

Anthem’s secret:
How this CRDMO powers global pharma innovation

Mind-blowing revenue and profit growth (and what it means for investors)

Why debt-free and high margin matters for small-cap success

The moat: How Anthem stacks up against
Divi’s Labs
Syngene
Laurus Labs

The key risks every investor should know

What institutional buying really signals



💡 If you invest in Indian stocks and mutual funds, this is a must-watch!



👇 Are you tracking Anthem? Already invested or waiting for the next move? Share your thoughts in the comments!



👍 Like | 💬 Comment | 🔔 Subscribe for smart, simple investing content!



Disclaimer:
This content is for informational and educational purposes only. It is not investment advice or a recommendation to buy, sell, or hold any security. Please do your own research or consult with a financial advisor before making any investment decisions. The video may mention stocks, but always invest based on your personal financial situation and risk tolerance.

Watch the latest video to discover:
https://youtu.be/IDUveWM67vA

7 months ago | [YT] | 0

Finance Tutor

🚨 India’s Pharma Empire: The Secret Kingpin Revealed! 🚨

Ever wondered how the medicines in your local pharmacy get there? There’s a hidden player quietly building a pharma supply chain empire by snatching up 39 companies in just 7 years—without any retail headaches or flashy consumer discounts!

🔍 In my latest video, I break down:

- The “Zomato Model” for pharma distribution
- The power of tech & scale in healthcare delivery
- Massive profit jumps and accelerating growth
- How this stealth operator compares with Apollo and Reliance-backed giants
- Future plans: more deals, better margins, and premium positioning

💊 If you want to understand India’s pharma business—and spot hidden investment opportunities—don’t miss this deep dive!

https://youtu.be/fnaUUt0T-9s

**Disclaimer:** This video and post are for educational purposes only—not a buy or sell recommendation. Please do your own research and consult a SEBI-registered financial advisor before making any investment decisions.

Watch now and let me know:
Are you bullish on India’s pharma distribution space? Drop your thoughts in the comments 👇

#Pharma #StockMarketIndia #BusinessModel #IndianEconomy #HiddenGems

7 months ago | [YT] | 0

Finance Tutor

🚀 Kaynes Technology: India's Next 100x Growth Story?



Remember when Bajaj Finance was just ₹700 crore in revenue? Today, it’s close to ₹70,000 crore! 📈 Now, imagine an electronics manufacturing company doing something similar—introducing Kaynes Technology: from ₹424 crore to ₹2,722 crore in just 4 years, a mind-blowing 60% CAGR!



💡 Why is Kaynes an unstoppable growth machine?

5 Segments: Industrial+EV, Automotive, Railways, Medical, Aero & Defense—all explosive markets!


Beating competitors (Dixon, Syrma, Amber) with 15%+ margins

Fortress of certifications: AS9100, IATF 16949, IRIS, ISO 13485—years of investment!

Customer Stickiness: 90%+ retention, 85% satisfaction, 60% revenue from long-term contracts

Debt-Light Model: Only 0.2 D/E



🔮 Future Roadmap:

$1 billion revenue by FY28

$2 billion by FY30


Major expansion: OSAT Sanand, HDI PCB Chennai, North America entry 🚀

Is Kaynes Technology India’s next Bajaj Finance? Watch my full analysis on the channel for insights, numbers, and roadmap.
👇
#KaynesTechnology #Multibagger #StockMarketIndia #MakeInIndia #GrowthStocks #EMS #Investing101 #BajajFinance #NextBigThing



https://youtu.be/UPAgTLYRhuQ

Disclaimer : This post is for educational purpose. Consult your financial advisor before taking any investment decisions. I am not a SEBI registered investment advisor.

7 months ago | [YT] | 0